Inhibition of Ovarian Epithelial Carcinoma Tumorigenesis and Progression by microRNA 106b Mediated through the RhoC Pathway
出版年份 2015 全文链接
标题
Inhibition of Ovarian Epithelial Carcinoma Tumorigenesis and Progression by microRNA 106b Mediated through the RhoC Pathway
作者
关键词
Ovarian cancer, Transfection, MicroRNAs, Cancer treatment, Benign tumors, Apoptosis, Mouse models, Metastasis
出版物
PLoS One
Volume 10, Issue 5, Pages e0125714
出版商
Public Library of Science (PLoS)
发表日期
2015-05-02
DOI
10.1371/journal.pone.0125714
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Expression of miR-106b-25 induced by salvianolic acid B inhibits epithelial-to-mesenchymal transition in HK-2 cells
- (2014) Qiong Tang et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- An investigation into anti-proliferative effects of microRNAs encoded by the miR-106a-363 cluster on human carcinoma cells and keratinocytes using microarray profiling of miRNA transcriptomes
- (2014) Cuong Khuu et al. Frontiers in Genetics
- Downregulation of miR-106b induced breast cancer cell invasion and motility in association with overexpression of matrix metalloproteinase 2
- (2013) Xiaojian Ni et al. CANCER SCIENCE
- The role of RhoC in ovarian epithelial carcinoma: A marker for carcinogenesis, progression, prognosis, and target therapy
- (2013) Yang Zhao et al. GYNECOLOGIC ONCOLOGY
- De-Regulated MicroRNAs in Pediatric Cancer Stem Cells Target Pathways Involved in Cell Proliferation, Cell Cycle and Development
- (2013) Patricia C. Sanchez-Diaz et al. PLoS One
- Fibronectin induces MMP2 expression in human prostate cancer cells
- (2012) Andrei Moroz et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Heading off with the herd: how cancer cells might maneuver supernumerary centrosomes for directional migration
- (2012) Angela Ogden et al. CANCER AND METASTASIS REVIEWS
- MicroRNAs and the cell cycle
- (2011) María José Bueno et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- Mechanisms of microRNA deregulation in human cancer
- (2011) Shan Deng et al. CELL CYCLE
- Shielding the messenger (RNA): microRNA-based anticancer therapies
- (2011) Elena Sotillo et al. PHARMACOLOGY & THERAPEUTICS
- Matrix Metalloproteinases: Regulators of the Tumor Microenvironment
- (2010) Kai Kessenbrock et al. CELL
- Roles of matrix metalloproteinases in cancer progression and their pharmacological targeting
- (2010) Chrisostomi Gialeli et al. FEBS Journal
- Clinical characteristics of TIMP2, MMP2, and MMP9 gene polymorphisms in colorectal cancer
- (2010) Kyung Sook Park et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- miRNAs in human cancer
- (2010) Thalia A Farazi et al. JOURNAL OF PATHOLOGY
- RhoC expression level is correlated with the clinicopathological characteristics of ovarian cancer and the expression levels of ROCK-I, VEGF, and MMP9
- (2009) Yang Zhao et al. GYNECOLOGIC ONCOLOGY
- The role of RhoC in growth and metastatic capacity of melanoma
- (2009) Barbara Boone et al. JOURNAL OF CUTANEOUS PATHOLOGY
- RhoC Expression and Head and Neck Cancer Metastasis
- (2009) M. Islam et al. MOLECULAR CANCER RESEARCH
- Causes and consequences of microRNA dysregulation in cancer
- (2009) Carlo M. Croce NATURE REVIEWS GENETICS
- Possible role of the RhoC/ROCK pathway in progression of clear cell renal cell carcinoma
- (2008) Hideyuki ABE et al. BIOMEDICAL RESEARCH-TOKYO
- Specific activation of microRNA106b enables the p73 apoptotic response in chronic lymphocytic leukemia by targeting the ubiquitin ligase Itch for degradation
- (2008) D. Sampath et al. BLOOD
- Genomic Profiling of MicroRNA and Messenger RNA Reveals Deregulated MicroRNA Expression in Prostate Cancer
- (2008) S. Ambs et al. CANCER RESEARCH
- MicroRNA Expression Profiles in Serous Ovarian Carcinoma
- (2008) E. J. Nam et al. CLINICAL CANCER RESEARCH
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started